Skip to main content
. 2021 Mar 1;7:20. doi: 10.1038/s41523-021-00231-x

Table 1.

Patient characteristics (n = 77,425).

Characteristic Number (%)
Age (median, IQR) 59 (50–65)
Race
White 67998 (87.8%)
Black 5750 (7.4%)
Other 3096 (4.0%)
Unknown 581 (0.8%)
LVI
Present 9856 (12.7%)
Absent 59,305 (76.6%)
Unknown 8264 (10.7%)
Tumor size (mm)
0–20 59,396 (76.7%)
21–50 18,029 (23.3%)
Lymph node involvement
0 65,018 (84.0%)
1–3a 12,407 (16.0%)
Grade
1 21,069 (27.2%)
2 40,188 (51.9%)
3 12,077 (15.6%)
Unknown 4091 (5.3%)
Recurrence score
0–10 17,390 (22.5%)
11–25 48,398 (62.5%)
26–100 11,637 (15.0%)
Charlson–Deyo comorbidities
0 65,906 (85.1%)
1 9761 (12.6%)
2 1433 (1.8%)
3 or more 325 (0.4%)
Median income quartile
<$38,000 9001 (11.6%)
$38,000–$47,999 15,080 (19.5%)
$48,000–$62,999 21,028 (27.2%)
>$63,000 32,146 (41.6%)
Median educational levelb
1 (17.6% or more) 8222 (10.6%)
2 (10.9%–17.5%) 16,236 (21.0%)
3 (6.3%–10.8%) 26,636 (34.5%)
4 (<6.3%) 26,190 (33.9%)

aIncludes micrometastatic nodal involvement.

b% of adults > age 25 in patients’ zip code without high school diploma, expressed in quartiles.